Live from the NIH registry
Studies recruiting near Hagerstown right now
Top 25 of 107 recruiting studies, sorted by proximity — each links to its official registry page
Secukinumab Open Label Roll-over Extension Protocol
Autoimmunity, Inflammation
Phase 4
Interventional 1,000 participants sought
Klein and Associates — Hagerstown, Maryland (0.1 mi)
· Sponsor: Novartis Pharmaceuticals
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Psoriatic Arthritis
Phase 3
Interventional 1,182 participants sought
Klein and Associates, M.D., P.A. — Hagerstown, Maryland (0.1 mi)
· Sponsor: Takeda
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Multiple conditions
Phase 2
Interventional 98 participants sought
Chambersburg Hospital — Chambersburg, Pennsylvania (20.8 mi)
· Sponsor: NRG Oncology
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Ability x Ottobock.care — Frederick, Maryland (22.8 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Breast Cancer
N/A
Observational 1,800 participants sought
Meritus Center for Clinical Research — Hagerstown, Maryland (0.1 mi)
· Sponsor: Exact Sciences Corporation
Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants
Macular Telangiectasia Type 2 (MacTel)
Phase 4
Interventional 234 participants sought
Cumberland Valley Retina Consultants — Frederick, Maryland (22.8 mi)
· Sponsor: Neurotech Pharmaceuticals
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Breast Carcinoma, Colorectal Carcinoma
N/A
Observational 2,000 participants sought
WellSpan Medical Oncology and Hematology — Chambersburg, Pennsylvania (20.8 mi)
· Sponsor: Wake Forest University Health Sciences
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
FMH James M Stockman Cancer Institute — Frederick, Maryland (22.8 mi)
· Sponsor: National Cancer Institute (NCI)
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Chambersburg Hospital — Chambersburg, Pennsylvania (20.8 mi)
· Sponsor: Novo Nordisk A/S
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
Cancer, Immunotherapy
N/A
Observational 2,000 participants sought
Frederick Health Hospital — Frederick, Maryland (22.8 mi)
· Sponsor: Elephas
Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body
Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion
N/A
Observational 150 participants sought
Frederick Health-James M Stockman Cancer Institute — Frederick, Maryland (22.8 mi)
· Sponsor: Bayer
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Pancreatic Neoplasm
N/A
Observational 770 participants sought
WVUH-Berkely Medical Center — Martinsburg, West Virginia (18.1 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma
Phase 3
Interventional 269 participants sought
Chambersburg Hospital — Chambersburg, Pennsylvania (20.8 mi)
· Sponsor: NRG Oncology
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Geographic Atrophy, Macular Degeneration
Phase 2, Phase 3
Interventional 274 participants sought
Cumberland Valley Retina Consultants — Hagerstown, Maryland (0.1 mi)
· Sponsor: Janssen Research & Development, LLC
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Macular Degeneration, Age-Related Macular Degeneration
Phase 2, Phase 3
Interventional 960 participants sought
Mid Atlantic Retina Specialists — Hagerstown, Maryland (0.1 mi)
· Sponsor: EyeBiotech Ltd.
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Phase 2
Interventional 461 participants sought
WVUH-Berkely Medical Center — Martinsburg, West Virginia (18.1 mi)
· Sponsor: National Cancer Institute (NCI)
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
Phase 3
Interventional 2,000 participants sought
Research Site — Chambersburg, Pennsylvania (20.8 mi)
· Sponsor: DalCor Pharmaceuticals
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Age-related Macular Degeneration (AMD), Geographic Atrophy (GA)
Phase 3
Interventional 975 participants sought
Cumberland Valley Retina Consultants-Ophthalmology — Hagerstown, Maryland (0.1 mi)
· Sponsor: Regeneron Pharmaceuticals
A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTO
Diabetic Macular Edema (DME)
Phase 3
Interventional 910 participants sought
Kodiak Research Center — Hagerstown, Maryland (0.1 mi)
· Sponsor: Kodiak Sciences Inc
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Lung Non-Small Cell Carcinoma
Phase 2
Interventional 88 participants sought
WellSpan Medical Oncology and Hematology — Chambersburg, Pennsylvania (20.8 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Evaluate the Efficacy and Safety of OTX-TKI (Axitinib Implant) in Participants With Non-Proliferative Diabetic Retinopathy
Non-Proliferative Diabetic Retinopathy
Phase 3
Interventional 930 participants sought
Cumberland Valley Retina Consultants — Hagerstown, Maryland (0.1 mi)
· Sponsor: Ocular Therapeutix, Inc.
Understanding and Addressing Risks of Low Socioeconomic Status and Diabetes for Heart Failure
Type2diabetes, Heart Failure
N/A
Interventional 156 participants sought
Johns Hopkins University Comstock Center — Hagerstown, Maryland (0.1 mi)
· Sponsor: Johns Hopkins University
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
Phase 3
Interventional 228 participants sought
WVUH-Berkely Medical Center — Martinsburg, West Virginia (18.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Diabetic Macular Edema, DME
Phase 3
Interventional 240 participants sought
Cumberland Valley Retina Consultants — Hagerstown, Maryland (0.1 mi)
· Sponsor: EyePoint Pharmaceuticals, Inc.
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
Irritable Bowel Syndrome
Phase 2
Interventional 95 participants sought
Frederick County Pediatrics /ID# 234519 — New Market, Maryland (30.0 mi)
· Sponsor: AbbVie